We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$696M
AUM Growth
-$17.3M
Cap. Flow
-$537K
Cap. Flow %
-0.08%
Top 10 Hldgs %
15.81%
Holding
288
New
40
Increased
95
Reduced
57
Closed
17

Top Buys

Rank Stock Value
1
FRSH icon
Freshworks
FRSH
+$10.8M
2
JBL icon
Jabil
JBL
+$4.39M
3
GSK icon
GSK
GSK
+$4.1M
4
NOV icon
NOV
NOV
+$3.97M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.76M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$11.3M
2
VNM icon
VanEck Vietnam ETF
VNM
+$7M
3
CHX
ChampionX
CHX
+$4.45M
4
GPN icon
Global Payments
GPN
+$4.34M
5
UNH icon
UnitedHealth
UNH
+$4.03M

Sector Composition

Rank Sector Weight
1 Technology 31.67%
2 Industrials 12.69%
3 Healthcare 11.3%
4 Energy 7.93%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
51
Boeing
BA
$165B
$4.47M 0.64%
24,557
-786
-3% -$140K
FANG icon
52
Diamondback Energy
FANG
$57.6B
$4.46M 0.64%
22,272
+1,068
+5% +$212K
PTC icon
53
PTC
PTC
$13.7B
$4.37M 0.63%
24,060
-165
-0.7% -$29.5K
CG icon
54
Carlyle Group
CG
$16.3B
$4.36M 0.63%
108,707
+976
+0.9% +$42.1K
COR icon
55
Cencora
COR
$60.3B
$4.36M 0.63%
19,353
+858
+5% +$199K
VAL icon
56
Valaris
VAL
$5.51B
$4.36M 0.63%
58,489
+68
+0.1% +$4.92K
VLO icon
57
Valero Energy
VLO
$89.8B
$4.28M 0.61%
27,274
+1,305
+5% +$211K
ELV icon
58
Elevance Health
ELV
$81.9B
$4.24M 0.61%
7,826
+357
+5% +$189K
CVX icon
59
Chevron
CVX
$388B
$4.15M 0.6%
26,507
+1,347
+5% +$215K
GSK icon
60
GSK
GSK
$103B
$4.13M 0.59%
107,167
+97,578
+1,018% +$4.1M
ASAN icon
61
Asana
ASAN
$1.58B
$4.1M 0.59%
293,037
-35,211
-11% -$502K
AL
62
DELISTED
Air Lease Corp
AL
$4.1M 0.59%
86,249
+687
+0.8% +$33.4K
LMT icon
63
Lockheed Martin
LMT
$134B
$4.08M 0.59%
8,729
+407
+5% +$188K
LHX icon
64
L3Harris
LHX
$55.9B
$4.06M 0.58%
18,071
+932
+5% +$201K
MRVL icon
65
Marvell Technology
MRVL
$174B
$4.05M 0.58%
58,006
+1,954
+3% +$137K
NOV icon
66
NOV
NOV
$7.45B
$4.03M 0.58%
+212,026
New +$3.97M
VRNT
67
DELISTED
Verint Systems
VRNT
$4.01M 0.58%
124,470
+478
+0.4% +$15.2K
JBL icon
68
Jabil
JBL
$32.8B
$3.94M 0.57%
+36,189
New +$4.39M
CIVI
69
DELISTED
Civitas Resources
CIVI
$3.93M 0.56%
56,905
-1,529
-3% -$111K
CAE icon
70
CAE Inc. Common Shares
CAE
$8.1B
$3.91M 0.56%
210,223
+35,222
+20% +$682K
SF
71
Stifel
SF
$12.3B
$3.86M 0.56%
68,889
+4,381
+7% +$232K
SNA icon
72
Snap-on
SNA
$20.9B
$3.86M 0.56%
14,780
-444
-3% -$122K
AOS icon
73
A.O. Smith
AOS
$8.38B
$3.79M 0.54%
46,364
-1,817
-4% -$154K
NBIX icon
74
Neurocrine Biosciences
NBIX
$17.7B
$3.78M 0.54%
+27,443
New +$3.76M
FIVN icon
75
FIVE9
FIVN
$1.77B
$3.72M 0.53%
84,280
-6,806
-7% -$354K
1 2
3
4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q2 2024 Portfolio in Review

As of Q2 2024, Stanley-Laman Group held 288 positions worth $696M, down 2.4% from $713M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q2 2024 filing shows 40 new, 95 increased, 57 reduced and 17 closed positions. Its largest new stake was Freshworks: 719,687 shares worth $9.13M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q2 2024 buy was Freshworks: 719,687 shares worth $9.13M.
  • Stanley-Laman Group added most to GSK in Q2 2024, an estimated $4.1M increase.
  • Stanley-Laman Group's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $3.55M.
  • Stanley-Laman Group fully exited HashiCorp, Inc. Class A Common Stock in Q2 2024, selling an estimated $11.3M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $696M portfolio in Q2 2024.
  • Stanley-Laman Group opened 40 new positions and closed 17 in Q2 2024.
  • Stanley-Laman Group's portfolio value fell 2.4% quarter-over-quarter to $696M.

Based on Stanley-Laman Group's 13F filing for Q2 2024, filed 18 Jul 2024.